BBPart 1
BBPart 1
Blood Bank I
D. Joe Chaffin, MD
Summit Pathology, Greeley, CO
Bonfils Blood Center, Denver, CO
Blood Bank I
Blood Groups
I. Basic Antigen-Antibody Testing
A. Basic Red Cell-Antibody Interactions
1. Agglutination
a. Clumping of red cells due to antibody coating
b. Main reaction we look for in Blood Banking
c. Two stages:
1) Coating of cells (“sensitization”)
a) Affected by specificity of antibody,
electrostatic charge of RBCs, temperature,
relative amounts of antigen and antibody
b) Substances like Low Ionic Strength Saline
(LISS) and Polyethylene glycol (PEG) aid in
sensitization by helping to overcome physical
barriers to let antigens and antibodies get
closer to each other
2) Formation of bridges
a) Lattice-like structures formed by antibodies
and red cells
b) IgG isn’t good at this; it is usually too small
to bridge the gap between red cells by itself
c) IgM is much better at forming bridges
2. Hemolysis
a. Direct lysis of a red cell as a result of antibody
coating is uncommon, but is just as much a
“positive” as agglutination
1) Requires complement fixation
2) IgM antibodies do this more than IgG
B. Tube Testing
1. Immediate spin “phase”
a. Serum and 2-5% RBC solution together in tube,
centrifuge for 15-30 sec, and examine.
1) Most common: 2 drops serum, 1-2 drops RBCs.
2. 37 C “phase”
a. Take above mixture and incubate at 37 C for
specified time, centrifuge, and examine.
1) 10-15 minutes if LISS used to potentiate
2) 15-30 minutes if albumin or PEG used
3) 30-60 minutes if no potentiation used
3. Indirect antiglobulin (a.k.a., “antihuman globulin”)
“phase”
1) Wash above mixture to remove unbound
globulins.
2) Add antihuman globulin, centrifuge, and
examine.
C. Alternatives to tube testing
1. Column agglutination technology
a. Gel testing (Ortho)
1) Multiple microtubes filled with gel particles and
anti-IgG reagent
a) Gel particles separate red cell clusters by size
(i.e., larger clumps of cells are stopped from
migrating through gel while individual cells
cruise right on through to the bottom)
b) Anti-IgG grabs onto red cells coated by IgG
2) Add red cells and plasma to top of tube,
incubate, then centrifuge
3) More coating of red cells by antibody = larger
agglutinates and more attraction to antiglobulin
in gel = less transport through gel
a) Negative gel tests show cells in a button at
the bottom of the microtube
b) Positive tests have cells spread in varying
degrees through the microtube
4) Can be automated (ProVue machine)
b. Affinity column testing (REACT; not currently
available)
1) Similar appearance, but no antiglobulin
2) IgG-binding proteins in column
3. IAT Variations
a. Can be used to check for an unknown antibody by
using red cells with a known antigen profile, as in
an antibody screen
b. Can be used to check for an unknown red cell
antigen by using serum with known antibody
specificity, as in RBC antigen testing
c. Can be used to check for a reacting unknown
antigen and unknown antibody, as in the
crossmatch procedure
06Chaff1.doc (6/11/08) Blood Bank I Page 3
Pathology Review Course
4. Specificities of the antiglobulin
a. Anti-IgG, -C3d (“polyspecific”)
1) Will detect red cells coated with either of the
above, and may also detect other
immunoglobulins (because the anti-IgG is not
specific)
b. Anti-IgG and anti-IgG (heavy chains)
1) Both detect IgG-coated red cells; anti-IgG may
also detect light chains associated with other
antibody classes (IgA, IgM)
c. Anti-C3b, -C3d
1) Detects either of the above complement
components
2) Useful in evaluating IgM-related hemolysis, cold
agglutinin disease, and certain warm
autoimmune hemolysis without IgG
5. IgG-coated red cells (“Coomb’s control”)
a. Used after negative DAT or IAT to ensure proper
functioning of antiglobulin reagent
b. IgG-coated RBCs added to AHG-cell mixture
c. Negative = bad AHG or no AHG added
d. Other errors in the process (leaving out the test
serum, bad processing technique, etc) would not be
detected by Coomb’s Control test
E. Dosage
1. Certain antibodies do not react as strongly with RBCs
that have antigens coded for by a single gene.
2. For example, imagine a hypothetical anti-Z
a) Patient 1 genotype: ZZ (Homozygous for Z)
b) Patient 2 genotype: ZY (Heterozygous for Z)
c) If anti-Z shows dosage, it will react stronger with
patient 1’s RBCs (see below)
RBC Genotype Reaction with anti-Z
ZZ 3+
ZY 1+
F. Neutralization
1. A particular substance, when mixed with an antibody,
eliminates the activity of that antibody against test red
cells
2. Some of these are pretty weird! (See table on next
page)
“WARM-REACTIVE” “COLD-REACTIVE”
ANTIBODIES ANTIBODIES
IgG IgM
Require exposure Naturally occurring
Cause HDN No HDN*
Cause HTRs No HTRs*
“Significant” “Insignificant”*
f. *Note that the ABO blood group is the exception in
the table above.
2. The “Enzyme Classification”
Lectin Specificity
Dolichos biflorus A1, Sda
Ulex europaeus H
Vicea graminea N
Forward Reverse
ABO
Anti- Anti- A1 B Group
A B cells cells
4+ 0 0 4+ A
0 4+ 4+ 0 B
4+ 4+ 0 0 AB
0 0 4+ 4+ O
Wiener’s “Haplotypes”
(with DCE Equivalents)
R1: DCe r’: dCe
R2: DcE r”: dcE
R0: Dce r: dce
Rz: DCE ry: dCE
Insignificant Significant